Cooper Companies Analyst Ratings
Piper Sandler Maintains Overweight on Cooper Companies, Maintains $115 Price Target
Cooper Co (COO) Gets a Buy From Piper Sandler
Baird Adjusts Price Target on Cooper Companies to $118 From $116
Buy Rating Affirmed for The Cooper Companies Inc. on Robust Q2 Earnings and Strong Growth Prospects
Needham: Reiterates that Cooper Companies (COO.US) holds the rating.
Cooper Companies Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH)
Needham: Reiterates that Cooper Companies (COO.US) holds the rating.
Cooper Companies Analyst Ratings
Buy Rating Affirmed for Cooper Companies Amid Strong Growth Prospects and Positive Industry Trends
Cooper Companies (NASDAQ:COO): Analysts Are Bullish on This MedTech S&P 500 Stock
Cooper Companies Analyst Ratings
Buy Rating Affirmed for Cooper Companies, Inc. on Optimistic FY2024 Outlook and Strategic Market Positioning
Cooper Companies Analyst Ratings
Cooper Companies Upgraded at J.P. Morgan on Outlook
Cooper Companies Analyst Ratings
J.P. Morgan Remains a Hold on Cooper Co (COO)
Piper Sandler Adjusts Price Target on Cooper to $115 From $110, Maintains Overweight Rating
Mizuho Maintains Buy on Cooper Companies, Raises Price Target to $115